Skip to content

External Nitric Oxide Measurement Through SNO Degradation

Does a Flashlight Used to Detect Pet Biological Fluids on Human Skin and Other Surfaces Increase Gas Phase Nitric Oxide Levels?

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04903535
Enrollment
150
Registered
2021-05-26
Start date
2021-05-10
Completion date
2026-12-30
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Unconscious

Brief summary

In this study, we aim to explore the feasibility of a novel, noninvasive SNO assay to acquire physiological SNO quantification from various parts of the human body and test this new method of analysis. This study aims to help with the currently cumbersome and invasive procedures used to measure SNOs in the body. The proposed activities do not unnecessarily duplicate previous experiments.

Detailed description

S-nitrosylation is the covalent attachment of a nitric oxide group to cystine thiol within a protein to form an S-nitrosothiol (SNO); it has diverse regulatory roles in all mammalian cells and thus operates as a fundamental mechanism for cellular signaling and accounts for a large part of nitric oxide activity. Though SNOs are relevant to many biological disciplines like neuronal, muscular, respiratory, and cardiovascular biology, currently there is no way to measure SNOs that is both easy to use in a clinical setting and accurate in detecting low concentrations; detection is challenging due to the labile nature of the molecules. Low or high concentrations of these molecules could be vital indicators of incoming dangerous issues in the body. A system to easily and accurately measure SNOs could prove useful in preventative treatments. Ultra Violet (UV) light can break SNOs and can be used to measure nitric oxide release, but this method is not fully developed and further research is needed on the potential effect for UV to measure nitric oxide release.

Interventions

DEVICEAlonefire SV003 10W 365nm UV Flashlight

Investigator will use a Nitric Oxide Analyzer while attached to a small suction port on the subject's ear lobe to be tested for Nitric Oxide. After getting the baseline assay, the investigator will shine a low-intensity UV Flashlight (Alonefire SV003 10W 365nm UV Flashlight) at the ear lobe for 10 seconds, repeated three times at 20 second intervals, to determine if there is photobleaching. Then the assay will then be performed on the opposite ear lobe. Fifteen minutes after the third UV flashlight exposure, the investigator will collect air from the subject's ear during photolysis into a 20mL glass syringe (once from each ear). Fifteen minutes after the third UV flashlight exposure, the investigator will collect air from the subject's ear during photolysis into a 20mL glass syringe (once from each ear). The subject and the investigator will wear UV goggles during the experiment.

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Healthy Volunteers

Eligibility

Sex/Gender
ALL
Age
1 Days to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult males or females age ≥ 1 day and ≤ 75 years at time of enrollment

Exclusion criteria

* Subjects meeting the following criteria will be excluded: * Smokers. * Any chronic skin conditions. * Pregnant. * Subjects that are unable or unwilling to cooperate with specimen collection. * Subjects with diagnosis of any medical condition that in the investigator's opinion would make them unsuitable for study participation. * (for subjects ≥ 18) Subjects that lack the capacity to consent for themselves.

Design outcomes

Primary

MeasureTime frameDescription
Change in Nitric Oxide during UV light exposure30 minutesNO evolved during UV light exposure from the human ear lobe, hand or forehead.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORNadzeya Marozkina, PhD, MD

Indiana University School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026